Search results
Showing 1 to 4 of 4 results for dithranol
Grenz rays therapy for inflammatory skin conditions (IPG236)
Evidence-based recommendations on Grenz rays therapy for inflammatory skin conditions. This involves exposing the skin to low-energy, non-penetrative electromagnetic radiation.
View recommendations for IPG236Show all sections
Sections for IPG236
Deucravacitinib for treating moderate to severe plaque psoriasis (TA907)
Evidence-based recommendations on deucravacitinib for treating moderate to severe plaque psoriasis in adults.
This guideline covers assessing and managing psoriasis in adults, young people and children. It aims to improve long-term disease control and quality of life for people with psoriasis.
Evidence-based recommendations on baricitinib (Olumiant) for treating severe alopecia areata in adults.